Vicarious Surgical Inc. (RBOT) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
Vicarious Surgical Inc. stock (RBOT) is currently trading at $0.90. Analyst consensus price target for RBOT is $5.00. WallStSmart rates RBOT as Sell.
- RBOT PE ratio analysis and historical PE chart
- RBOT PS ratio (Price-to-Sales) history and trend
- RBOT intrinsic value — DCF, Graham Number, EPV models
- RBOT stock price prediction 2025 2026 2027 2028 2029 2030
- RBOT fair value vs current price
- RBOT insider transactions and insider buying
- Is RBOT undervalued or overvalued?
- Vicarious Surgical Inc. financial analysis — revenue, earnings, cash flow
- RBOT Piotroski F-Score and Altman Z-Score
- RBOT analyst price target and Smart Rating
Vicarious Surgical Inc.
📊 No data available
Try selecting a different time range
Smart Analysis
Vicarious Surgical Inc. (RBOT) · 4 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in price/book. Concerns around market cap and return on equity. Significant fundamental concerns warrant caution or avoidance.
Vicarious Surgical Inc. (RBOT) Key Strengths (1)
Trading below book value, meaning the market prices it less than net assets
Supporting Valuation Data
Vicarious Surgical Inc. (RBOT) Areas to Watch (3)
Company is destroying shareholder value
Micro-cap company with very limited liquidity and high volatility
Moderate institutional interest at 32.73%
Vicarious Surgical Inc. (RBOT) Detailed Analysis Report
Overall Assessment
This company scores 19/100 in our Smart Analysis, earning a F grade. Out of 4 metrics analyzed, 1 register as strengths (avg 10.0/10) while 3 fall into concern territory (avg 3.0/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on Price/Book. Valuation metrics including Price/Book (0.75) suggest the stock is attractively priced.
The Bear Case
The primary concerns are Return on Equity, Market Cap, Institutional Own.. Profitability pressure is visible in Return on Equity at -177.50%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Return on Equity improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at -177.50% needing improvement to support the investment thesis. Third, top-line growth trajectory.
Risk Considerations
Based on the metric profile, this is a higher risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Fundamental challenges outweigh strengths at current levels. Return on Equity and Market Cap are the primary drags. Consider waiting for meaningful improvement before committing capital.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
RBOT Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
WallStSmart Analysis Synopsis
Data-driven financial summary for Vicarious Surgical Inc. (RBOT) · HEALTHCARE › MEDICAL DEVICES
The Big Picture
Vicarious Surgical Inc. operates as a stable business with moderate growth and solid fundamentals. The company is currently unprofitable, posting a 0.0% profit margin.
Key Findings
Free cash flow is -9M, meaning the company is burning cash. This may be acceptable for high-growth companies investing heavily.
What to Watch Next
Volatility is elevated with a beta of 1.55, so expect amplified moves relative to the broader market.
Sector dynamics: monitor MEDICAL DEVICES industry trends, competitive moves, and regulatory changes that could impact Vicarious Surgical Inc..
Bottom Line
Vicarious Surgical Inc. offers stability with moderate growth and solid fundamentals. The valuation may present an opportunity for patient investors, though limited growth means returns will likely come from dividends and modest capital appreciation rather than explosive gains.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions(2 last 3 months)
Data sourced from SEC Form 4 filings
Last updated: 8:24:26 AM
About Vicarious Surgical Inc.(RBOT)
NYSE
HEALTHCARE
MEDICAL DEVICES
USA
Vicarious Surgical Inc. (RBOT) is an innovative medical technology company focused on transforming surgical practices through its state-of-the-art robotic surgical systems that enhance precision and improve patient outcomes. By combining advanced robotics with artificial intelligence, Vicarious Surgical is pioneering a new era of minimally invasive surgery, offering surgeons superior dexterity, visualization, and control. The company's proprietary platform not only enhances surgical efficiency but also strives to minimize patient recovery times, thereby responding to the increasing demand for robotic-assisted procedures. As a leader in the rapidly growing surgical robotics market, Vicarious Surgical is dedicated to advancing patient care and addressing the evolving challenges within the healthcare sector.